Global cancer tissue diagnostics market is poised to register a CAGR of 8.3% over the forecast period. Growing at this pace, the market will become worth close to US$ 4,350 Mn in 2016 to nearly US$ 9,650 Mn till 2026.
In recent years, rising prevalence of cancer coupled with growing demand for personalized medicine are anticipated to propel the growth of the tissue diagnostic market. growing awareness about tissue diagnosis in emerging economies is expected to act as the most prominent factors behind the growth of this market.
Considering these factors, Market Research Reports Search Engine (MRRSE) has been recently included a new report titled “Cancer Tissue Diagnostics Market: Global Industry Analysis and Opportunity Assessment 2016-2026” to its vast repository. This intelligent study includes data related to the current as well as future market status, with a keen focus on prime market drivers and opportunities.
According to the study key findings, the global cancer tissue diagnostics market is poised to register a CAGR of 8.3% over the forecast period. Growing at this pace, the market will become worth close to US$ 4,350 Mn in 2016 to nearly US$ 9,650 Mn by 2026 end.
At present, the number of biomarkers that can be utilized for early cancer detection from blood or plasma samples are constantly increasing, which is expected to bring new cancer biomarker tests in the market in the near future, which as a result propelling the growth of cancer tissue diagnostics market.
Tissue diagnostics are important diagnostic techniques mainly used for diagnosis and management of cancer. Initially, the report starts with an executive summary that gives a concise overview of the cancer tissue diagnostics market along with key market segment and regions.
The section of the report is devoted to explaining the market definitions of the cancer tissue diagnostics market by various types of cancer treatment detection. Different cancer types considered in the scope of the global cancer tissue diagnostics market report include breast cancer, lung cancer, colorectal cancer, melanoma, blood cancers (Hodgkin & non-Hodgkin lymphoma, leukemia, myeloma.), prostate cancer, ovarian cancer, stomach cancer and liver cancer.
On the other hand, Hospitals, research laboratories, ambulatory surgical centers (ASCs), and diagnostic centers are the prime end users of tissue diagnostic products and services.
The geographical bifurcation includes North America, Asia Pacific, Middle East and Africa, Europe and Latin America as the prime regions for assessing the market size. In terms of geography, North America has dominated the global cancer tissue diagnostics market in revenue terms in 2016, and this trend is projected to continue throughout the forecast period.
Moreover, the research highlights various key dynamics supporting the growth of the market. It has been analyzed that meeting the needs of hospital laboratories presents a significant opportunity for the growth of the global cancer tissue diagnostics market.
Further, a section covering detailed competitive landscape of the cancer tissue diagnostics market has been highlighted. This section comprises company profile including overview, financials, strategy, recent developments of leading players, which are Bio Rad Laboratories Inc., F.
Hoffmann-La Roche Ltd., Abcam plc., Abbott Laboratories, ROSETTA GENOMICS, Creative- Biolabs, Sigma-Aldrich Co. LLC and others.
Browse Full Report with TOC : www.mrrse.com/cancer-tissue-diagnostics-market
Category: Market Research Publishers and RetailersCompany about: What Makes MRRSE ? MRRSE stands for Market Research Reports Search Engine, the largest online catalog of latest market research reports based on industries, companies, and countries. MRRSE sources thousands of industry reports, market statistics, and company profiles from trusted entities and makes them available at a click. Besides well-known private publishers, the reports featured on MRRSE typically come from national statistics agencies, investment agencies, leading media houses, trade unio ...